Karen Anderson, PhD
Professor of Pharmacology and of Molecular Biophysics and Biochemistry; Co-Leader, Developmental Therapeutics, Yale Cancer Center; Co-Director Therapeutics/Chemotherapy Program
Years active at Yale: 1992- present
Dr. Anderson is being recognized for her leadership in mechanistic enzymology and structure-based drug design. Her work focuses on understanding how enzymes, playing critical roles in such diseases as cancer and infectious diseases, including AIDS, work at a molecular level. She uses that information to develop new drug therapies. Her recent work on new antiviral therapies to treat HIV infections in a long-term collaborative effort with Dr. William Jorgensen in Yale’s Department of Chemistry has led to the discovery of a promising preclinical candidate that is now under further development. Dr. Anderson has trained more than 40 graduate students and postdoctoral fellows who are now involved in biomedical research.
She is a co-director of Developmental Therapeutics in the Yale Comprehensive Cancer Center, and co-track director of Biochemistry, Quantitative Biology, and Structural Biology in the Yale Combined Program in the Biological and Biomedical Sciences. Dr. Anderson has received numerous awards, including Monsanto Research Achievement awards, the Dean’s Young Faculty Award, the Hull Cancer Research Award, YCC Breast Cancer Initiative Award, Gates Foundation Grand Challenge Award, and Department of Defense Lung Cancer Concept Award. She has published more than 200 research papers and was elected to the Connecticut Academy of Science and Engineering.